News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Jill Feldman: Dosing studies are critical!
Photo taken from Jill Feldman/LinkedIn
May 9, 2024, 14:30

Jill Feldman: Dosing studies are critical!

Jill Feldman, Co-Founder of EGFR Resisters, shared a post on X:

“Dosing studies are critical!
OS and QOL both matter and pts/fam are the ONLY ones who can choose what matters most to THEM Amgen Oncology (and many others) please consider alternate doses while doing further studies
PhRMA, please push MED (minimal effective), NOT MTD.”

Read further.
Source: Jill Feldman/X

Amgen Oncology cancer EGFR Resisters Jill Feldman OncoDaily Oncology PhRMA
Special Coverage
Insight
Jun 25, 2025, 17:58
Shankar Siva: We Randomised the Final Patient on TROG Cancer Research 19.06 DECREASE Trial
Blog
Jun 25, 2025, 17:39
Julie Gralow: Pleased to Participate in This Well-organized Best of ASCO UAE Program in Abu Dhabi
Science
Jun 25, 2025, 16:50
Cedric Blanpain Shares New Study on the Role of Innate Immunity in Regulating Cell Plasticity and Reprogramming of Prostate Tumor Initiating Cells
Blog
Jun 25, 2025, 16:24
Results From Amgen's Phase 2 Obesity Study of Monthly Maritide Presented at the American Diabetes Association 85th Scientific Sessions
Blog
Jun 25, 2025, 16:13
Help Shape the Future of Cancer Care - Digestive Cancers Europe
Blog
Jun 25, 2025, 15:39
Raffaele Colombo: Dato-DXd Now Approved for Patients with EGFR-mutated NSCLC
Science
Jun 25, 2025, 15:25
Nakul Shah: Our Latest Review on Precision Oncology is out in The Oncologist
Blog
Jun 25, 2025, 14:56
Vaishali Paliwal Joins IGCS's Jump4June Challenge during Uterine Cancer Awareness Month
Blog
Jun 25, 2025, 14:30
Hathal Haddad: Salvage Brachytherapy - A Second Chance for Local Control
Blog
Jun 25, 2025, 14:17
Kyle Todd Shared New White Paper Analyzing Clinical Development Trends Across 594 ADCs with 142 Distinct Targets
Blog
Jun 25, 2025, 14:06
Renjith Vijayakumar Selvarani: An Indian-based startup OLUSIUM is breaking new ground in cancer diagnostics
Insight
Jun 25, 2025, 13:56
Loay Kassem Announced the Launch of "Not Her Journey Alone" Breast Cancer Educational Series with AstraZeneca Egypt